Navigation Links
Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Side Effects Litigation

New York, New York (PRWEB) June 15, 2013

Hundreds of Pradaxa lawsuit claims continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to court documents, the Court held a Status Conference on June 10th, at which time issues involving witness depositions were addressed.    The Court has scheduled the Pradaxa side effect litigation’s next Status Conference for July 9, 2013. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“We are pleased to see that progress continues in this litigation. Our Firm continues to receive inquiries from patients who used this blood thinner, and allegedly suffered serious Pradaxa side effects associated with life-threatening internal bleeding,”says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Pradaxa side effect claims evaluations to patients who have suffered serious internal bleeding, allegedly due to this drug.
Pradaxa Side Effects

Court filings indicate that 1,075 Pradaxa side effects lawsuits are currently pending in the Southern District of Missouri. All of the lawsuits allege use of the blood thinner caused plaintiffs to suffer from life-threatening episodes of Pradaxa bleeding, and accuse Boehringer Ingelheim of failing to adequately warn that there was no readily-available antidote for the serious internal bleeding that can sometimes accompany use of the drug.
Pradaxa is a blood thinner that was approved by the U.S. Food & Drug Administration (FDA) in October 2010, and is used to prevent strokes in people suffering from atrial fibrillation.

According to a report from December 2012, several government regulators have issued warnings regarding Pradaxa side effects, especially its association with life-threatening internal bleeding. * The Institute for Safe Medicine Practices also recently reported that its analysis of hemorrhage cases reported to the FDA during the second quarter of 2012 found that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding.**

Alleged victims of Pradaxa side effects may be entitled to compensation for their medical bills, lost wages, pain and suffering and more. Additional information on filing a Pradaxa lawsuit is available at Bernstein Liebhard LLP’s website. To arrange for a free legal consultation, please call 800-511-5092.

**Bloomberg, December 11, 2012;
***ISMP, January 9, 2013;

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Lawsuit News: Bernstein Liebhard LLP Notes Pradaxa Bleeding Claims Pending in Federal Litigation Now Exceed 1,000
2. Latest Pradaxa Internal Bleeding Problem Allegation Lawsuits Update; Resource4thePeople Reports Judge Schedules Important Hearing
3. New Lawsuit on Alleged Pradaxa Wrongful Death: Now, AttorneyOne Can Provide Advice
4. Pradaxa Lawsuits Move Ahead As Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation
5. Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports
6. New Lawsuit on Pradaxa Brain Hemorrhage: Now, AttorneyOne Can Provide Advice
7. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
8. Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation
9. Pradaxa Lawsuit Update: Bernstein Liebhard LLP Notes Filings in Federal Pradaxa Litigation Surpass 700
10. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
11. Rottenstein Law Group LLP Responds to Study Linking Pradaxa Side Effects with Potential Mortality Risks
Post Your Comments:
(Date:10/13/2015)... ... 13, 2015 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... Commitment to Cure last night at the Mandarin Oriental in New York City. ...
(Date:10/13/2015)... ... October 13, 2015 , ... The documentary Pink & Blue: Colors ... Beverly Hills October 2 - 8, coinciding with National Hereditary Breast & Ovarian Cancer ... takes us through the lives of women - and men - who are dealing ...
(Date:10/13/2015)... ... October 13, 2015 , ... Purdue University ... the Life Sciences Initiative aimed at enhancing Purdue’s life sciences research and graduate ... True” capital campaign. , The investment will result in cohesive efforts across several ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... enterprise focused on cancer patients, today announced a new partnership with the ... battling this rare type of non-Hodgkin’s lymphoma, their families and physicians. , ...
(Date:10/13/2015)... Diego, CA (PRWEB) , ... October 13, 2015 ... ... launch of its newest technology platform, ENGAGE, at HIMSS’s Patient Engagement Summit ... to end. , ENGAGE delivers innovative health programs and interventions via mobile devices ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)...  Graduate students across the country, with an ... soon have the opportunity to learn about a ... discovery and development process. Eli Lilly and Company ... leaders from academic institutions to create an elective ... Drug Development."  Lilly will formally unveil the eLearning ...
(Date:10/13/2015)... SAN FRANCISCO , October 13, 2015 ... expected to reach USD 26.8 billion by 2022, according ... Anesthesia and respiratory devices, owing to their capability to ... expected to witness a substantial growth. --> ... reach USD 26.8 billion by 2022, according to a ...
(Date:10/13/2015)... , Oct. 13, 2015   Micell Technologies ... DESSOLVE I and II trials of its MiStent Sirolimus ... ® ) were presented at the 27th Annual ... San Francisco , October 11-15. TCT ... cardiovascular medicine. MiStent SES was designed to optimize vessel ...
Breaking Medicine Technology: